BR0211453A - Composição sólida que contém esporos de bactérias não patogênicas do gênero bacillus - Google Patents

Composição sólida que contém esporos de bactérias não patogênicas do gênero bacillus

Info

Publication number
BR0211453A
BR0211453A BR0211453-4A BR0211453A BR0211453A BR 0211453 A BR0211453 A BR 0211453A BR 0211453 A BR0211453 A BR 0211453A BR 0211453 A BR0211453 A BR 0211453A
Authority
BR
Brazil
Prior art keywords
composition containing
pathogenic bacteria
solid composition
genus bacillus
containing spores
Prior art date
Application number
BR0211453-4A
Other languages
English (en)
Other versions
BRPI0211453B1 (pt
Inventor
Tiziano Prato
Original Assignee
Sanofi Synthelabo Otc S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo Otc S P A filed Critical Sanofi Synthelabo Otc S P A
Publication of BR0211453A publication Critical patent/BR0211453A/pt
Publication of BRPI0211453B1 publication Critical patent/BRPI0211453B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

"COMPOSIçãO SóLIDA QUE CONTéM ESPOROS DE BACTéRIAS NãO PATOGêNICAS DO GêNERO BACILLUS". A invenção refere-se a uma composição de esporos de bactérias não-patogênicas do gênero Bacillus adsorvidas em uma matriz formada por pelo menos um composto adsorvente insolúvel na água e por um derivado da celulose, suscetível de ser obtido pela técnica do leito de ar fluidizado, útil nos domínios farmacêutico, veterinário e da nutrição.
BRPI0211453-4A 2001-07-27 2002-07-26 Composição de esporos de bactérias não patogênicas do gênero bacillus adsorvidas em uma matriz e seu processo de obtenção BRPI0211453B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2001A001632 2001-07-27
IT2001MI001632A ITMI20011632A1 (it) 2001-07-27 2001-07-27 Composizione solida contenente spore di batteri non patogeni del genere bacillus
PCT/EP2002/008384 WO2003011341A1 (fr) 2001-07-27 2002-07-26 Composition solide contenant des spores de bacteries non pathogenes du genre bacillus

Publications (2)

Publication Number Publication Date
BR0211453A true BR0211453A (pt) 2004-08-17
BRPI0211453B1 BRPI0211453B1 (pt) 2018-04-03

Family

ID=11448170

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0211453-4A BRPI0211453B1 (pt) 2001-07-27 2002-07-26 Composição de esporos de bactérias não patogênicas do gênero bacillus adsorvidas em uma matriz e seu processo de obtenção

Country Status (32)

Country Link
US (2) US8039006B2 (pt)
EP (1) EP1429808B1 (pt)
JP (1) JP4913986B2 (pt)
KR (2) KR20090099022A (pt)
CN (1) CN1323720C (pt)
AT (1) ATE462448T1 (pt)
AU (1) AU2002333278B2 (pt)
BR (1) BRPI0211453B1 (pt)
CA (1) CA2454389C (pt)
CO (1) CO5560587A2 (pt)
CY (1) CY1112608T1 (pt)
DE (1) DE60235819D1 (pt)
DK (1) DK1429808T3 (pt)
EA (1) EA006847B1 (pt)
ES (1) ES2356325T3 (pt)
GE (2) GEP20063721B (pt)
HK (1) HK1061644A1 (pt)
HR (1) HRP20040066B1 (pt)
HU (1) HU229652B1 (pt)
IL (2) IL159807A0 (pt)
IT (1) ITMI20011632A1 (pt)
MA (1) MA27051A1 (pt)
MX (1) MXPA04000835A (pt)
NO (1) NO332656B1 (pt)
NZ (1) NZ530743A (pt)
PL (1) PL209647B1 (pt)
PT (1) PT1429808E (pt)
SI (1) SI1429808T1 (pt)
TN (1) TNSN04018A1 (pt)
UA (1) UA81225C2 (pt)
WO (1) WO2003011341A1 (pt)
ZA (1) ZA200400440B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599631B2 (en) 2001-01-26 2003-07-29 Nanogram Corporation Polymer-inorganic particle composites
KR100931948B1 (ko) * 2007-06-26 2009-12-15 영남대학교 산학협력단 제올라이트를 이용한 바실러스 포자의 열 안정성 향상 방법
BE1018018A6 (nl) 2008-02-28 2010-04-06 Gielen Cornelis Oplossing voor het biologisch reinigen van tandenborstels en bijhorende inrichting.
ES2694148T3 (es) 2008-04-07 2018-12-18 Bayer Cropscience Ag Combinaciones de agentes de control biológico y fungicidas
KR20110007168A (ko) * 2008-04-07 2011-01-21 바이엘 크롭사이언스 엘피 안정한 포자-함유 수성 제제
IT1393931B1 (it) 2009-02-25 2012-05-17 Neuroscienze Pharmaness S C A R L Composizione di spore di batteri non patogeni
US20110244031A1 (en) * 2010-03-31 2011-10-06 Lifecycle Pharma A/S Porous tablets as carriers for liquid formulations
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
CN104955466A (zh) * 2012-11-23 2015-09-30 赛里斯治疗公司 协同细菌组合物和其制造方法和用途
EP3904502A3 (en) 2013-02-04 2022-02-23 Seres Therapeutics, Inc. Compositions and methods
JP6479685B2 (ja) 2013-02-04 2019-03-06 セレス セラピューティクス インコーポレイテッド 病原性細菌生育の抑制のための組成物および方法
CA2906921A1 (en) 2013-03-15 2014-09-18 Seres Therapeutics, Inc. Network-based microbial compositions and methods
JP6833514B2 (ja) 2013-11-25 2021-02-24 セレス セラピューティクス インコーポレイテッド 相乗作用のある細菌組成物ならびにその製造及び使用方法
WO2015095241A2 (en) 2013-12-16 2015-06-25 Seres Health, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
EP3668527A1 (en) 2017-08-14 2020-06-24 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
US11278578B2 (en) * 2018-09-02 2022-03-22 Sanzyme Biologics Private Limited Combination probiotic compositions and uses thereof
FR3125945A1 (fr) * 2021-08-03 2023-02-10 Setalg Composition pour protéger un microorganisme dans un environnement acide.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1061894A (en) * 1963-03-01 1967-03-15 Lucien Nouvel Therapeutically active bacterial preparations
GB8425487D0 (en) * 1984-10-09 1984-11-14 Agricultural Genetics Co Strain of bacillus thuringiensis
DE3707160A1 (de) * 1987-03-06 1988-09-15 Hoechst Ag Bacillus polymyxa enthaltende mittel zur verabreichung an tiere
JPH0761255B2 (ja) 1990-10-31 1995-07-05 旭化成工業株式会社 安定化芽胞形成生菌製剤の製造法
DE4404702A1 (de) * 1994-02-15 1995-08-31 Hoechst Schering Agrevo Gmbh Wasserdispergierbare Granulate auf der Basis lebender Organismen
DK0746310T3 (da) * 1994-02-23 1999-08-02 Bm Res As Præparat med styret afgivelse
NZ288185A (en) * 1994-06-15 1998-02-26 Dumex Alpharma As Particulate pharmaceutical formulation containing coated cores comprising at least 80% of an inert carrier having a friability of <20%; the inert carrier can be calcium carbonate
DE4442255A1 (de) * 1994-11-28 1996-05-30 Bayer Ag Schädlingsbekämpfungsmittel
JP3180886B2 (ja) 1995-06-07 2001-06-25 旭化成株式会社 動物成長促進剤
ATE314858T1 (de) 1998-04-01 2006-02-15 Ganeden Biotech Inc Erfahren zür verringerung von cholesterin mit bacillus coagulans sporen, systeme un zusammensetzungen
US6924133B1 (en) * 1999-10-01 2005-08-02 Novozymes A/S Spray dried enzyme product
US6387874B1 (en) * 2001-06-27 2002-05-14 Spartan Chemical Company, Inc. Cleaning composition containing an organic acid and a spore forming microbial composition

Also Published As

Publication number Publication date
US8551498B2 (en) 2013-10-08
GEP20063721B (en) 2006-01-10
HK1061644A1 (en) 2004-09-30
ATE462448T1 (de) 2010-04-15
BRPI0211453B1 (pt) 2018-04-03
EA200400072A1 (ru) 2004-08-26
JP2004538311A (ja) 2004-12-24
CN1323720C (zh) 2007-07-04
ITMI20011632A1 (it) 2003-01-27
US20040241772A1 (en) 2004-12-02
HRP20040066B1 (en) 2012-02-29
UA81225C2 (en) 2007-12-25
CO5560587A2 (es) 2005-09-30
WO2003011341A1 (fr) 2003-02-13
MXPA04000835A (es) 2004-05-14
AU2002333278B2 (en) 2007-05-31
CA2454389A1 (fr) 2003-02-13
HUP0402024A2 (hu) 2005-01-28
US8039006B2 (en) 2011-10-18
US20120009167A1 (en) 2012-01-12
EA006847B1 (ru) 2006-04-28
KR20090099022A (ko) 2009-09-18
JP4913986B2 (ja) 2012-04-11
DE60235819D1 (de) 2010-05-12
ZA200400440B (en) 2005-03-30
HUP0402024A3 (en) 2005-06-28
CY1112608T1 (el) 2016-02-10
CA2454389C (fr) 2011-07-12
CN1558776A (zh) 2004-12-29
HRP20040066A2 (en) 2004-06-30
TNSN04018A1 (fr) 2006-06-01
NZ530743A (en) 2005-08-26
NO332656B1 (no) 2012-11-26
HU229652B1 (en) 2014-03-28
PL366984A1 (en) 2005-02-07
ITMI20011632A0 (it) 2001-07-27
KR20040032868A (ko) 2004-04-17
PL209647B1 (pl) 2011-09-30
MA27051A1 (fr) 2004-12-20
ES2356325T3 (es) 2011-04-07
SI1429808T1 (sl) 2010-11-30
KR100970787B1 (ko) 2010-07-16
IL159807A (en) 2010-05-31
NO20040347L (no) 2004-03-26
PT1429808E (pt) 2010-06-23
DK1429808T3 (da) 2010-07-19
IL159807A0 (en) 2004-06-20
EP1429808A1 (fr) 2004-06-23
EP1429808B1 (fr) 2010-03-31
GEP20053721B (en) 2006-01-10

Similar Documents

Publication Publication Date Title
BR0211453A (pt) Composição sólida que contém esporos de bactérias não patogênicas do gênero bacillus
BR0008911A (pt) Bactérias patogênicas da cepa lactobacillus para a prevenção de diarréia
BR0315209A (pt) Formulações nutritivas que contêm substâncias simbióticas
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
BR0012992A (pt) Bifidobactérias que previnem a diarréia causada por bactérias patogênicas
BRPI0615785B8 (pt) composição inibidora da absorção de colesterol compreendendo bactérias do gênero bifidobacterium
HUP0303728A2 (hu) Tápanyagkészítmény
UY26734A1 (es) Nuevos probióticos para aplicaciones de alimento de mascotas
ATE135228T1 (de) Pharmazeutische zubereitung zur kontrolle pathogener intestinaler bakterien
BR0008920A (pt) Cepas de lactobacillus capazes de prevenirdiarréia causada por bactéria patogênica erotaviroses
BR0009663A (pt) Composições de vacinas antibacterianas
RU2001104332A (ru) Биопрепарат для защиты растений от грибных и бактериальных болезней
NO20014788D0 (no) En sammensetning for senkning av konsentrasjonen av sykdomsfremkallende tarmpeptider
AR034920A1 (es) Metodos para el tratamiento de enfermedades intestinales inflamatorias
ATE301469T1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
ATE261732T1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
WO2006066224A3 (en) Virulence targeted antibiotics
ATE171072T1 (de) Rezeptor-konjugate zum targeting von arzneiwirkstoffen und anderen wirksubstanzen
KR950018031A (ko) 복합 올리고당 조성물
BR9806851A (pt) ComposiçÊes farmaceuticas e alimenticias que contêm bactérias de gênero acetobacter
KR950031083A (ko) 동물용 약제조성물
BR0115182A (pt) Composição de substância carreadora de produtos à base de papaìna e hialuronidase
ES2076107A1 (es) Derivados de antibioticos macrolidos de anillos de 16 miembros.
TH51761A (th) Lactobacillus สายพันธุ์ใหม่ที่ป้องกันอุจจาระร่วงที่เกิดจากแบคทีเรียก่อโรค
RU94001170A (ru) Противогрибковый препарат &#34;нихлоргин&#34;

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: PARA.INT.CI.A61K 47/38, A61K 35/74, A61P 1/00

Ipc: A61K 47/38 (2011.01), A61K 35/74 (2011.01), A61P 1

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 47/38 , A61K 35/74 , A61P 1/00

Ipc: A61K 35/74 (2006.01), A61K 47/38 (2006.01), A61P 1

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ART. 8O COMBINADO COM ART. 11 E 13 E ART. 24 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 22A ANUIDADE.